Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $1.46 million. The enterprise value is -$1.81 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APVO has 1.46 million shares outstanding.
Current Share Class | 1.46M |
Shares Outstanding | 1.46M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +186.34% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 4.93% |
Float | 1.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.36 |
P/TBV Ratio | 0.32 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.14.
Current Ratio | 1.72 |
Quick Ratio | 1.40 |
Debt / Equity | 1.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -284.28% and return on invested capital (ROIC) is -110.74%.
Return on Equity (ROE) | -284.28% |
Return on Assets (ROA) | -76.06% |
Return on Invested Capital (ROIC) | -110.74% |
Return on Capital Employed (ROCE) | -262.17% |
Revenue Per Employee | n/a |
Profits Per Employee | -$652,162 |
Employee Count | 37 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.43% in the last 52 weeks. The beta is 5.24, so APVO's price volatility has been higher than the market average.
Beta (5Y) | 5.24 |
52-Week Price Change | -99.43% |
50-Day Moving Average | 3.20 |
200-Day Moving Average | 8.85 |
Relative Strength Index (RSI) | 19.29 |
Average Volume (20 Days) | 83,722 |
Short Selling Information
The latest short interest is 120,620, so 8.27% of the outstanding shares have been sold short.
Short Interest | 120,620 |
Short Previous Month | 60,058 |
Short % of Shares Out | 8.27% |
Short % of Float | 8.27% |
Short Ratio (days to cover) | 2.61 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -24.60M |
Pretax Income | -24.95M |
Net Income | -24.13M |
EBITDA | -24.25M |
EBIT | -24.60M |
Earnings Per Share (EPS) | -$87.38 |
Full Income Statement Balance Sheet
The company has $8.71 million in cash and $5.40 million in debt, giving a net cash position of $3.32 million or $2.27 per share.
Cash & Cash Equivalents | 8.71M |
Total Debt | 5.40M |
Net Cash | 3.32M |
Net Cash Per Share | $2.27 |
Equity (Book Value) | 4.76M |
Book Value Per Share | 3.26 |
Working Capital | 4.45M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -23.79M |
Capital Expenditures | n/a |
Free Cash Flow | -23.79M |
FCF Per Share | -$16.31 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1,606.16% |
FCF Yield | -1,583.19% |
Analyst Forecast
The average price target for APVO is $296.00, which is 29,556.35% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $296.00 |
Price Target Difference | 29,556.35% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.027027:1.
Last Split Date | Dec 4, 2024 |
Split Type | Reverse |
Split Ratio | 0.027027:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |